000			02356nam a22006614u 4500
001			10.1079/9780851995809.0000
003			CABI
005			20231004110326.0
007			cr nn 008mam|a
008			020221t2002||||xxu fs| |0|| 0|eng||
020			_a9780851997001 _qelectronic
024	7		_a10.1079/9780851995809.0000 _2doi
041			_aeng
245	0	0	_aAgricultural biotechnology and transatlantic trade: regulatory barriers to GM crops _h[electronic resource] _cEdited by G. E. Isaac.
260			_aWallingfordUK _bCABI Publishing _c2002
264		1	_aWallingfordUK _bCABI Publishing _c2002
300			_a303pp.;
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _2rdaft
347			_bPDF
490	1		_aCABI Books
520			_aGenetically modified (GM) agricultural crops which are approved as safe in North America (Canada and the United States) are facing significant regulatory hurdles in gaining access to the European Union. The development and commercialization of GM crops illustrate a complex challenge facing trade diplomacy - the challenge of regulatory regionalism created by social regulatory barriers.
653	0	0	_abiotechnology
653	0	0	_aUnited States of America
653	0	0	_aCommonwealth of Nations
653	0	0	_aEurope
653	0	0	_aUSA
653	0	0	_aGMOs
653	0	0	_agenetically modified organisms
653	0	0	_aNorth America
653	0	0	_agenetically modified plants
653	0	0	_aEuropean Union Countries
653	0	0	_aregulations
653	0	0	_aAPEC countries
653	0	0	_anon-tariff barriers to trade
653	0	0	_aOECD Countries
653	0	0	_aGEOs
653	0	0	_agenetically engineered plants
653	0	0	_abiosafety
653	0	0	_agenetically engineered organisms
653	0	0	_aCanada
653	0	0	_atransgenic plants
653	0	0	_atransgenic organisms
653	0	0	_aDeveloped Countries
653	0	0	_atrade relations
653	0	0	_aeukaryotes
653	0	0	_arules
653	0	0	_ainternational trade
653	0	0	_aAmerica
653	0	0	_aplants
700	1		_aIsaac, G. E. _4edt
776	0	8	_iPrinted edition: _z9780851995809
830		0	_aCABI Books
856	4	0	_uhttps://cabi-prod.literatumonline.com/action/showBook?doi=10.1079%2F9780851995809.0000
942			_cEB
999			_c315382 _d315382